Shareholders Equity: The sum of preferred and common equity items.
OKYO Pharma Limited Sponsored ADR (OKYO) had Shareholders Equity of $12.34M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$20.97M |
|
$0.01M |
|
$0.01M |
|
$20.98M |
|
$8.64M |
|
-- |
|
-- |
|
$8.64M |
|
$12.34M |
|
$12.34M |
|
|
Shareholders Equity |
$12.34M |
-- |
|
| Cash Flow Statement Financials | |
$-5.94M |
|
$-6.01M |
|
$25.02M |
|
$1.56M |
|
$14.59M |
|
$13.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|